Orionis Biosciences

Genentech Orionis Biosciences collaboration, Molecular glue drugs discovery, Allo-Glue platform Orionis, Genentech Roche protein degradation, Orionis Biosciences milestones and royalties, Molecular glue drugs oncology neurodegeneration, Genentech molecular glue deals,

Genentech and Orionis Biosciences team up to discover molecular glue drugs for oncology and neurodegeneration

Anika Sharma

Genentech, a subsidiary of Roche, is aggressively expanding its partnered portfolio into cutting-edge areas of research and development. Following a ...